nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibodies and other biomarkers – pathological consequences (2)
|
Ehrenstein, MR |
|
2008 |
17 |
3 |
p. 256-258 |
artikel |
2 |
Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?
|
Belizna, C |
|
2008 |
17 |
3 |
p. 185-194 |
artikel |
3 |
Autoantibodies and other biomarkers – pathological consequences (1)
|
Giles, I |
|
2008 |
17 |
3 |
p. 241-246 |
artikel |
4 |
Cellular interactions and signalling defects in lupus (1)
|
Zouali, M |
|
2008 |
17 |
3 |
p. 236-240 |
artikel |
5 |
E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in systemic lupus erythematosus
|
Lee, S-W |
|
2008 |
17 |
3 |
p. 195-201 |
artikel |
6 |
High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody–positive patients with autoimmune rheumatic disease
|
Muro, Y |
|
2008 |
17 |
3 |
p. 171-176 |
artikel |
7 |
Hypothyroidism determines the clinical and immunological manifestations of Arabs with lupus
|
Al Saleh, J |
|
2008 |
17 |
3 |
p. 215-220 |
artikel |
8 |
Introduction to a systemic lupus erythematosus – biomarkers meeting held at University College London on 23rd and 24th February 2007
|
Isenberg, David |
|
2008 |
17 |
3 |
p. 231-231 |
artikel |
9 |
Lupus: improving long-term prognosis
|
Doria, A |
|
2008 |
17 |
3 |
p. 166-170 |
artikel |
10 |
Origin and structure of autoantibodies and antigens in autoimmune rheumatic diseases
|
Rahman, A |
|
2008 |
17 |
3 |
p. 232-235 |
artikel |
11 |
Pathogenic factors for the development of lupus nephritis
|
Mason, LJ |
|
2008 |
17 |
3 |
p. 251-255 |
artikel |
12 |
Severe digital ischemia–a presenting symptom of malignancy–associated antiphospholipid syndrome
|
Grossman, A |
|
2008 |
17 |
3 |
p. 206-209 |
artikel |
13 |
Signalling defects and cellular interactions (2)
|
Datta, SK |
|
2008 |
17 |
3 |
p. 247-250 |
artikel |
14 |
Successful treatment of amegakaryocytic thrombocytopenia with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus
|
Fukushima, T |
|
2008 |
17 |
3 |
p. 210-214 |
artikel |
15 |
Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sjögren’s syndrome
|
Sánchez-Cano, D |
|
2008 |
17 |
3 |
p. 228-229 |
artikel |
16 |
Sulpha allergy in lupus patients: a clinical perspective
|
Jeffries, M |
|
2008 |
17 |
3 |
p. 202-205 |
artikel |
17 |
Systemic lupus erythematosus in the Fars Province of Iran
|
Nazarinia, MA |
|
2008 |
17 |
3 |
p. 221-227 |
artikel |
18 |
Therapeutic potential (2)
|
Silverman, GJ |
|
2008 |
17 |
3 |
p. 262-265 |
artikel |
19 |
Therapeutic potential (1)
|
Zack, Debra Jeske |
|
2008 |
17 |
3 |
p. 259-261 |
artikel |
20 |
Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort
|
Ramsey-Goldman, R |
|
2008 |
17 |
3 |
p. 177-184 |
artikel |
21 |
Viruses and lupus: the viral hypothesis
|
Ramos-Casals, Manel |
|
2008 |
17 |
3 |
p. 163-165 |
artikel |